Navigation Links
GeneGo Kicks Off The MetaMiner Stem Cell Project With Industry and Academics
Date:9/1/2009

ST. JOSEPH, Mich., Sept. 1 /PRNewswire/ -- GeneGo, Inc., the leading systems biology tools company, announced today that it launched a collaborative development project on systems biology of stem cells with global pharmaceutical companies and leading academic centers as members. The 24-month project aims to create a comprehensive "knowledge base" on development and biology of different types of stem cells. The knowledge base will be supported by GeneGo's MetaDiscovery tools and applied in experimental research on stem cells and human diseases.

"We are really excited about this project," said Yuri Nikolsky, CEO of GeneGo. "Although one of the hottest areas of life science, no systematic effort was done on methodical annotation of current experimental knowledge on stem cells, and we intend to fill this gap. Understanding the biology of embryonic adult and neoplastic stem cells is key in both drug discovery and fundamental research in many fields from embryology and ontogenesis to cancer and diabetes."

"We are very glad to be able to attract an excellent team of members for the cause," said Julie Bryant, GeneGo's VP of Business Development. "An industry-academia consortium model fits well with our development objectives in such a complex and controversial field. We believe that the members will see a strong positive return on their investment within several months from the project's launch."

About GeneGo, Inc.

GeneGo, Inc. develops systems biology technology such as compound based pathway analysis, cheminformatics & bioinformatics software for life science research. The original computational MetaDiscovery((TM)) platform allows an integration and expert analysis of different kinds of experimental data (mRNA expression, proteomics, metabolomics, microRNA assays and other phenotypic data) and relevant bioactive chemistry (metabolites, drugs, other xenobiotics) within the framework of curated biological pathways and networks. GeneGo's flagship product, MetaCore 5.4((TM)), assists pharmaceutical scientists in the areas of target selection and validation, data mining in biology, identification of biomarkers for disease states and toxicology. The second product, MetaDrug 5.4((TM)) is designed for prediction of human metabolism, toxicity and biological effects for novel small molecules compounds. MetaBase((TM)) represents the knowledge base for MetaCore.

For more information, please visit the company's web site at www.genego.com.


'/>"/>
SOURCE GeneGo, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. GeneGo Donates Proprietary Cytokine Pathway Maps to ISICR
2. Cardiff University Becomes a GeneGo Center of Excellence
3. Childrens Memorial Research Center, Chicago Becomes a Member of GeneGos MetaMiner Stem Cell Partnership Program
4. GeneGo Announces Systems Tox Relationship With Entelos
5. Millipore Launches an Interactive Biological Pathway Tool Using GeneGos Manually Curated Pathway Maps
6. Queensland Facility for Advanced Bioinformatics (QFAB) Becomes a GeneGo Center of Excellence for the Asia Pacific Region
7. University of Glasgow Becomes a Member of GeneGos MetaMiner Stem Cell Partnership Program
8. Pacific Northwest National Laboratories Becomes a GeneGo Center of Excellence
9. GeneGo Renews Its Agreement With Bayer Schering Pharma AG for Another Three Years
10. The Burnham Institute for Medical Research Becomes a GeneGo Center of Excellence Using MetaCore for Stem Cell Research and Neurology
11. GeneGo Is Awarded NCI Grant for Development of Systems Biology Database and Tools for Nutrition in Cancer in Collaboration with the FDA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2017)... ... July 24, 2017 , ... ... the stock market news outlet had initiated coverage on Interpace Diagnostics. Interpace ... and identifies exposure, progression and risk analysis from specific cancers in humans. ...
(Date:7/20/2017)... ... 20, 2017 , ... Resoundant, Inc. is pleased to introduce ... the U.S. that offer MR Elastography for liver fibrosis staging. MR Elastography ... staging liver fibrosis assessment. , “MRE:connect was created in response to an increasing ...
(Date:7/20/2017)... ... 20, 2017 , ... Litmus Health , a clinical ... advisory board. The board comprises leaders spanning business, technology, academia, and pharmaceutical research. ... of Engineering, to Chief Technology Officer. Crooks will lead strategy and development of ...
(Date:7/20/2017)... ... July 20, 2017 , ... Corista, a leader in integrated ... Tuesday, July 25, during the Association of Pathology Chairs’ Jubilee Meeting in Washington, ... Baras, Associate Director of Pathology Informatics, will present “The Digital Pathology Experience at ...
Breaking Biology Technology:
(Date:3/24/2017)... Research and Markets has announced the addition of the ... Forecast to 2025" report to their offering. ... The Global Biometric Vehicle Access System ... over the next decade to reach approximately $1,580 million by 2025. ... forecasts for all the given segments on global as well as ...
(Date:3/23/2017)... 2017 Research and Markets has announced the ... Trends - Industry Forecast to 2025" report to their offering. ... The Global ... of around 8.8% over the next decade to reach approximately $14.21 ... market estimates and forecasts for all the given segments on global ...
(Date:3/22/2017)... Optimove , provider of the ... as 1-800-Flowers and AdoreMe, today announced two new ... Using Optimove,s machine learning algorithms, these features allow ... recommendations to their customers based not just on ... intent drawn from a complex web of data ...
Breaking Biology News(10 mins):